Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07187297 · ClinicalTrials.gov registry record · NA

A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment

A NA study of Wrinkle and Lax Skin, sponsored by Bausch Health Americas.

Recruiting
Registry status
NA
Development phase
164
Enrollment target
1
Study location

NCT07187297 is a NA study of Wrinkle and Lax Skin that is actively recruiting participants, run by Bausch Health Americas. The registered enrollment target is 164 participants, above the 114-participant average among 25 other Wrinkle trials with a reported enrollment target (44% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07187297, a NA study of Wrinkle and Lax Skin, is actively recruiting participants, sponsored by Bausch Health Americas.

RECRUITING
Registry status
NA
Development phase
164 participants
Enrollment target
1
Study location

Study Summary

A prospective, 180-day, randomized, multicenter, independent blinded evaluators, controlled study of treatment with the Thermage FLX System

Interventions

  • DEVICE Thermage FLX

Study Locations (1)

New York

  • Union Square Laser Dermatology - New York

Trial Details

FieldValue
Enrollment Target 164 participants
Start Date 2025-10-31
Est. Completion 2027-03
Phase NA

Sponsor

Bausch Health Americas

168 total trials

What the Registry Record Tells You About NCT07187297

The ClinicalTrials.gov registry entry for NCT07187297 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 164 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 114-participant average among 25 other Wrinkle trials with a reported enrollment target (44% higher). The listed sponsor is Bausch Health Americas, which has 168 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Wrinkle appearing as the primary indexed condition, and to 1 intervention - of which Thermage FLX is the first listed.

NCT07187297 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT07187297 about?

NCT07187297 is a clinical study titled "A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment". A prospective, 180-day, randomized, multicenter, independent blinded evaluators, controlled study of treatment with the Thermage FLX System

What is the current status of trial NCT07187297?

This trial is currently recruiting. It is a NA study. The enrollment target is 164 participants. The study started on 2025-10-31. Estimated completion is 2027-03.

What conditions does trial NCT07187297 study?

This clinical trial studies the following conditions: Wrinkle, Lax Skin, Lines Skin.

What interventions are being tested in trial NCT07187297?

The interventions under investigation include: Thermage FLX (DEVICE).

Who is sponsoring clinical trial NCT07187297?

This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07187297 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Wrinkle

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.